Blog - Page 4722 of 5636

TuesdayApr 08, 2008 12:45 pm

Iomai Corp. (IOMI) Wins Cost-Reimbursement Grant from U.S. Army Medical Research and USAMRMC

Iomai, a company that discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology, announced it won the Department of Defense one-year grant to develop a stable, patch-based anthrax vaccine. Iomai scientists plan to use vaccine antigen developed by UK-based Avecia Biologics Ltd. in an attempt to formulate a dry version of antigen that can be combined with an Iomai adjuvant on a needle-free patch. After such time, Iomai will evaluate the stability of the patch to conclude whether it can be stored and shipped at room temperature. Currently the anthrax vaccine is administered as a…

TuesdayApr 08, 2008 12:38 pm

China 3C Group (CHCG.OB) Signs Wholesale Supply Agreement with Wal-Mart China

China 3C Group, a leading wholesale distributor and retailer operating over 900 retail outlets in Eastern China, entered into a supply agreement with Wal-Mart stores in Zhejiang Province to sell audio electronic equipment, including radios, stereo equipment and CD players, at all six Wal-Mart stores starting April 2008. This allows China 3C Group the possibility of expanding its distribution into other Wal-Mart stores that are located in Eastern China as well as other near provinces in the future. Wal-Mart currently has eighty-one stores in China with thirteen of those stores located in Eastern China. Mr. Wang Zheng-gang, Chairman and Chief…

TuesdayApr 08, 2008 12:37 pm

Jaco Electronics, Inc. (JACO) Awarded a Contract to Manufacture 4,500 Optical Scan Voting Machines for New York State Locations

Jaco Electronics, a leading distributor of electronic components to industrial OEMs and contract manufacturers, announced it has been awarded a contract to manufacture about 4,500 voting machines for use throughout New York State. The contract was awarded by Dominion Voting Systems, which is partnering with Sequoia Voting Systems in New York State. Jaco anticipates completing delivery during the summer of 2008, just in time for the November presidential election. Joel Girsky, Jaco’s Chairman and Chief Executive Officer said, “We are extremely pleased to once again work with Sequoia, and our new partner Dominion Voting. This agreement represents Jaco’s first voting…

TuesdayApr 08, 2008 11:34 am

Global Roaming Distribution Inc. (GRDB.OB) – Leading the Inexpensive Global Cell Phone Revolution

If you have ever traveled overseas on business or for pleasure and used your cell phone to call back to the office or home, then you are well aware how much international roaming charges can cost. The major carriers, AT&T, Verizon, Sprint and T-Mobile, charge anywhere from $1 to $5 per minute for international roaming. The same mobile carriers also offer special international plans, which charge a slightly lower rate per minute, but cost the subscriber an arm and a leg in monthly fees. Fortunately, there is a new solution to help international travelers ease the burden of these outrageous…

TuesdayApr 08, 2008 9:05 am

OTCPicks Featured Company: Expert Group, Inc. (EXPT.PK) Provides March 2008 Financial Numbers

Expert Group, Inc. (OTC: EXPT) recently announced their financial figures for the month of March, in which the company originated $1.3 million in loans, bringing a $50,000 net profit to the company. These numbers do not include payroll for the recent addition of ten new loan officers during the month of March, who were added to take advantage of Expert Group's building momentum. The company’s stock was up 130.00% on Monday. A company spokesperson commented, "We are understandably pleased to be able to announce the realization of net profitability. However, as far as we are concerned, this is just a…

TuesdayApr 08, 2008 8:45 am

Lebed.biz Featured Company: Pluristem Therapeutics Inc. (PSTI)

Pluristem Therapeutics Inc. (PSTI) is a leading bio-therapeutics company with research and manufacturing facilities located in Israel. The company derives its products from stem cells which are obtained from the placenta, a non-controversial source unlike embryonic stem cells. The company is seeking to commercialize these non-personalized stem-cell therapy products for the treatment of certain, severe autoimmune disorders. After obtaining these stem cells, Pluristem literally grows its product in a proprietary PLURI-X bio-reactor and the product is stored "ready-to-use". The bio-reactor mimics the natural microstructure of bone marrow so supplemental growth materials are not required. The company's initial product, called PLX-I,…

TuesdayApr 08, 2008 8:41 am

Communicate.com, Inc. (CMNN.OB) – Made-Over to Live Current Media Inc.

There are times when a company feels the need to do a drastic makeover in order to take its business to the next level. It could be that the old way of doing business is at a standstill and, in order to move the company into the future, changes are necessary. For some industry experts, the dot-com industry bubble ended with the new millennium. But some companies like Communicate.com, who still see the Internet as a way of generating profit, are changing the way they do business. Communicate.com builds, owns and operates some of the most powerful and engaging content…

TuesdayApr 08, 2008 8:19 am

StockGuru Trade Alert: Guru Profile bioMETRX (BMRX) Up More than 19% Tuesday Morning

StockGuru Trade Alert: Guru Profile bioMETRX (BMRX) Up More than 19% Tuesday Morning Yesterday’s Close: $0.21 Today’s High So Far: $0.25

TuesdayApr 08, 2008 8:18 am

StockGuru Blog: NextGen Bioscience (NXGB) and Its Work on Infectious Diseases

NextGen Bioscience, Inc. is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of cancers and infectious diseases in human beings. “NextGen” leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical companies. NextGen’s business model is to acquire promising new patented technologies in the fields of cancer and infectious disease, to add significant value to these by advancing them through toxicological assessment or Phase I clinical trials and then outlicensing the technology to a larger partner who has…

TuesdayApr 08, 2008 8:17 am

StockGuru Trade Alert: Profile Stock Lotus Pharmaceuticals (LTUS) Now Up More than 21% Since Friday

StockGuru Trade Alert: Profile Stock Lotus Pharmaceuticals (LTUS) Now Up More than 21% Since Friday Friday’s Close: $0.591 Today’s High So Far: $0.72 View the StockGuru Profile for LTUS: http://stockguru.com/profiles/ltus/

Site Search

Company Search